Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot fMRI of THC on Memory
NCT05116527Phase 2Active, not recruiting
- Sponsor
- Hartford Hospital
- Start
- Jul 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol (2 arms), sponsored by Hartford Hospital. Primary endpoints: Marijuana induced performance changes on fMRI Multi-Stage Decision Making (MSDM) Task, Marijuana induced performance changes on Relational and Item Specific Coding (RISE) fMRI Task and 2 more. Started Jul 2022; status: active, not recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT05116527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05116527.